Is it time to buy A2 Milk Company Ltd shares?

With the market sinking lower again following President Trump’s decision to fire his secretary of state Rex Tillerson, a number of popular shares have been dragged lower.

One such example is the A2 Milk Company Ltd (ASX: A2M) share price. In morning trade the infant formula and dairy company’s shares are down 1.5% to $12.83.

Should you buy the dip?

At 51x estimated full-year earnings and 30x estimated FY 2019 earnings, I think a2 Milk Company’s shares are close to being fair value now based on its current growth profile.

While I wouldn’t expect its shares to provide the same level of returns over the next 12 months as it has over the previous 12 months, if it continues to outperform expectations then I believe it shares have the potential to beat the market return.

I’m not alone in this view. The fast-growing company added another broker to its list of admirers this week.

According to a note out of Morgans, the broker has initiated coverage on a2 Milk Company with an add rating and a $14.40 price target.

Based on its current share price, this price target implies a potential share price return of over 12% over the next 12 months.

The broker appears to believe that a2 Milk Company is capable of continuing to deliver strong growth over next few years as it wins market share across China and other key markets.

Furthermore, Morgans thinks that the quality of its products, their premium price points, and their high margins means that the company’s shares are deserving of a premium rating.

I would have to agree with Morgans on this one and think that a2 Milk Company is the best option in the industry ahead of the likes of Bellamy’s Australia Ltd (ASX: BAL), Bubs Australia Ltd (ASX: BUB), and Wattle Health Australia Ltd (ASX: WHA).

Looking for the next star growth share like a2 Milk Company? Look no further than these future stars.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.